Tumor clones in the GR9 clone system vary in their MHC-I surface expression under baseline conditions, but these MHC-I alterations are reversible “soft lesions”, and MHC-I expression can be induced by IFN-γ treatment [44]. The gene discussed is IFNG; the disease is neoplasm.